NDC 52959-898 - Appbutamone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52959-898
- Package NDCs from labels
- 52959-898-30
- Manufacturer
- Physician Therapeutics LLC | Sandoz Inc | Targeted Medical Pharma Inc. | H.J. Harkins Company, Inc.
- Effective date
- 2011-08-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Appbutamone | Physician Therapeutics LLC | Sandoz Inc | Targeted Medical Pharma Inc. | H.J. Harkins Company, Inc. | 2011-08-08 | HUMAN PRESCRIPTION DRUG LABEL |
| Appbutamone-D | Physician Therapeutics LLC | Sandoz Inc | H.J. Harkins Company, Inc. | Targeted Medical Pharma Inc. | 2011-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52959-898-30 | Appbutamone-D | 30 in 1 BOTTLE | TABLET | 30 | 75 mg | 12 |
| 52959-898-30 | Appbutamone | 30 in 1 BOTTLE | TABLET | 30 | 75 mg | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 52959-898 | APPBUTAMONE-D (BUPROPION HYDROCHLORIDE, TYROSINE) KIT [PHYSICIAN THERAPEUTICS LLC] | 12 | Unmatched | 20110805_71359f14-0f8f-4e90-af1d-426e8c21bd61.zip |
| 52959-898 | APPBUTAMONE (BUPROPION HYDROCHLORIDE, TYROSINE) KIT [PHYSICIAN THERAPEUTICS LLC] | 5 | Unmatched | 20110808_f0c3cafa-8985-4dac-9be1-a92454a4ef6e.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.